1 Principles

General aspects

DSM-Firmenich AG is a stock corporation (Aktiengesellschaft) incorporated and domiciled in Switzerland. The Company is based in Kaiseraugst, Switzerland. DSM-Firmenich AG is the holding company of the operating companies of the dsm-firmenich Group, who is a leading supplier in nutrition, health and beauty.

The fiscal year-end of DSM-Firmenich AG (formerly Danube AG, ‘the Company’) is 31 December. These financial statements of DSM-Firmenich AG were prepared in accordance with Swiss Law on Accounting and Financial Reporting (32nd title of the Swiss Code of Obligations). Where not prescribed by law, the significant accounting and valuation principles applied are described below.

On 8 May 2023, the company published interim financial statements due to the dividends distributed during the year.

The financial statements are presented in euros (EUR or €); the Swiss franc (CHF) values are presented for the purposes of comparison and have been calculated by applying the period-end FX-rate. The comparative figures of the period ending 31 December 2022 were audited in CHF; the EUR amounts are presented for the purposes of comparison. All values in the financial statements are rounded to the nearest million, except when otherwise indicated.

Any main accounting policies applied in the preparation of these financial statements that are not already specified by law, i.e., by the Swiss Code of Obligations, are outlined below in the applicable notes.


The Company’s currency – as legally determined by the Articles of Association – is EUR, which is also the functional currency. The Company changed its currency, i.e., the denomination of its share capital in the Articles of Association of the Company, from CHF to EUR as of 1 January 2023 as adopted by the Extraordinary General Meeting on 18 April 2023. The Company has determined that for DSM-Firmenich AG as the holding company the primary economic environment is in EUR due to its public listing in EUR on the Euronext in Amsterdam (Netherlands) as of 18 April 2023.

Transactions in foreign currencies are recorded at the exchange rate at the date of the transaction. Assets and liabilities denominated in a foreign currency are translated into EUR at period-end exchange rates.

As required by the Swiss Code of Obligations (cf. art. 958d para. 3), the financial statements are also presented in the national currency, being CHF. The following EUR/CHF exchange rates have been applied in these financial statements to translate the balance sheet and income statement:

  • Closing rate on 31.12.2022: 0.9847
  • Closing rate on 31.12.2023: 0.9260

For the opening balance sheet as at 1 January 2023, the last audited balances in CHF have been translated to EUR with the closing rate EUR/CHF 0.9847

x thousand


Share capital


Reserves from capital contributions

Opening balance in CHF as of 1 January 2023





Opening balance in EUR as of 1 January 2023 – translated at closing date





Summary of the accounting policies

Cash and cash equivalents

Cash and cash equivalents comprise bank balances.


Investments in companies where the entity holds an investment are valued at acquisition cost less adjustments for impairment of value.

Foregoing a cash flow statement and additional disclosures in the notes

As DSM-Firmenich AG has prepared its consolidated financial statements in accordance with a recognised accounting standard (IFRS), it has decided to forego presenting additional disclosures as well as a cash flow statement in accordance with the law.

Topic filter